Trial Outcomes & Findings for A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter (NCT NCT05373862)

NCT ID: NCT05373862

Last Updated: 2025-03-03

Results Overview

Number of participants with pre-ablation mapping requirements and clinically indicated mapping performed with the investigational catheter without resort to non-study mapping catheter(s) were reported.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

Up to 7 days of index procedure on Day 1

Results posted on

2025-03-03

Participant Flow

Participant milestones

Participant milestones
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Overall Study
STARTED
40
Overall Study
COMPLETED
40
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Age, Continuous
58.0 years
STANDARD_DEVIATION 15.73 • n=40 Participants
Sex: Female, Male
Female
15 Participants
n=40 Participants
Sex: Female, Male
Male
25 Participants
n=40 Participants

PRIMARY outcome

Timeframe: Up to 7 days of index procedure on Day 1

Population: Per-protocol analysis set included all participants who completed the protocol-required "pre-ablation mapping" with the investigational catheter.

Number of participants with pre-ablation mapping requirements and clinically indicated mapping performed with the investigational catheter without resort to non-study mapping catheter(s) were reported.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Participants With Pre-ablation Mapping Requirements and Clinically Indicated Mapping Performed With the Investigational Catheter Without Resort to Non-study Mapping Catheter(s)
40 Participants

PRIMARY outcome

Timeframe: Up to 7 days of index procedure on Day 1

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.

Number of participants with SAEs within 7 days of index procedure related to the investigational catheter were reported. An adverse event (AE) is any untoward medical occurrence in a participant whether or not related to the investigational device. SAE is any AE that results in: death, persistent or significant disability/incapacity, requires inpatient hospitalization or prolongation of existing hospitalization, is life-threatening experience, is a congenital anomaly/birth defect and may jeopardize participant and/or may require medical or surgical intervention to prevent one of the outcomes listed above.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Participants With Serious Adverse Events (SAEs) Within 7 Days of Index Procedure Related to the Investigational Catheter
1 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for maneuverability \& handling were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for maneuverability and handling.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 2
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 3
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 4
6 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 5
7 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 6
14 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Atrium): Score 7
3 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 3
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 4
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 5
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 6
9 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Atrium): Score 7
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 4
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 5
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 6
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Left Ventricle): Score 7
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 4
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 5
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 6
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Deploy (Right Ventricle): Score 7
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 2
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 4
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 5
8 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 6
10 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Atrium): Score 7
9 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 4
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 5
7 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 6
7 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Atrium): Score 7
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 4
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 5
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 6
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Left Ventricle): Score 7
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 4
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 5
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 6
3 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Maneuver (Right Ventricle): Score 7
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 2
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 4
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 5
7 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 6
11 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Atrium): Score 7
8 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 4
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 5
5 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 6
8 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Atrium): Score 7
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 4
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 5
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 6
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Left Ventricle): Score 7
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 4
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 5
3 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 6
3 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to Reach Areas (Right Ventricle): Score 7
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 3
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 4
6 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 5
5 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 6
10 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Atrium): Score 7
10 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 4
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 5
3 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 6
9 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Atrium): Score 7
3 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 4
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 5
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 6
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Left Ventricles): Score 7
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 2
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 4
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 5
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 6
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Ability to withdraw (Right Ventricles): Score 7
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 2
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 4
6 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 5
11 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 6
20 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Overall ease of use of the catheter: Score 7
2 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 2
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 3
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 4
4 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 5
10 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 6
13 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Insertion and withdrawal from introducer sheath: Score 7
12 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 1
0 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 2
1 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 4
6 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 5
12 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 6
17 Participants
Number of Responders for Physician Assessment for Maneuverability and Handling
Learning curve: Score 7
4 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'N' (number of participants analyzed) signifies participants evaluated for this outcome measure and 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for signal collection and quality (UNIPOLAR signals in atria/ventricles, UNIPOLAR noise encountered, BIPOLAR signals in atria/ventricles, BASELINE noise encountered, and BIPOLAR noise encountered) were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for signal collection and quality.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=38 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 4
3 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 5
5 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 6
5 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Atria: Score 7
6 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 4
2 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 5
1 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 6
2 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR signals in Ventricles: Score 7
4 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 4
5 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 5
6 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 6
11 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
UNIPOLAR noise encountered: Score 7
6 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 4
4 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 5
6 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 6
7 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Atria: Score 7
15 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 4
1 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 5
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 6
2 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR signals in Ventricles: Score 7
7 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 4
5 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 5
7 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 6
12 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BASELINE noise encountered: Score 7
14 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 1
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 2
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 3
0 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 4
5 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 5
9 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 6
9 Participants
Number of Responders for Physician Assessment for Signal Collection and Quality
BIPOLAR noise encountered: Score 7
15 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'N' (number of participants analyzed) signifies participants evaluated for this outcome measure and 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for pacing (high output stimulation pacing and local pacing capture) were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for pacing.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=23 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 1
0 Participants
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 2
0 Participants
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 3
0 Participants
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 4
1 Participants
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 5
1 Participants
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 6
1 Participants
Number of Responders for Physician Assessment for Pacing
High output stimulation pacing: Score 7
2 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 1
0 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 2
1 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 3
2 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 4
4 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 5
7 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 6
4 Participants
Number of Responders for Physician Assessment for Pacing
Local pacing capture: Score 7
5 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.

Number of responders for physician assessment for catheter design were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for catheter design.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 2
1 Participants
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 4
4 Participants
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 5
11 Participants
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 6
22 Participants
Number of Responders for Physician Assessment for Catheter Design
Ability to achieve electrode contact with cardiac tissue: Score 7
2 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 4
4 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 5
10 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 6
13 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrodes spacing: Score 7
13 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 4
4 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 5
10 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 6
18 Participants
Number of Responders for Physician Assessment for Catheter Design
Electrode array coverage: Score 7
8 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for workflow were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for workflow.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 2
0 Participants
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 3
0 Participants
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 4
4 Participants
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 5
11 Participants
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 6
9 Participants
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 7
5 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 1
0 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 2
1 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 3
4 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 4
5 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 5
14 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 6
4 Participants
Number of Responders for Physician Assessment for Workflow
Ability to reduce fluoroscopy: Score 7
10 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 1
0 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 2
1 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 3
0 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 4
4 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 5
14 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 6
19 Participants
Number of Responders for Physician Assessment for Workflow
Time for pre-procedure mapping: Score 7
2 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 1
0 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 2
1 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 3
0 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 4
4 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 5
8 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 6
11 Participants
Number of Responders for Physician Assessment for Workflow
Time for post-procedure mapping after standard of care ablation: Score 7
12 Participants
Number of Responders for Physician Assessment for Workflow
Ability to identify targets: Score 1
0 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for catheter visualization were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for catheter visualization.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 4
5 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 6
18 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 5
9 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 6
9 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 2
2 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 5
10 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization under fluoroscopy: Score 7
3 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 3
4 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 4
6 Participants
Number of Responders for Physician Assessment for Catheter Visualization
Visualization in CARTO 3: Score 7
12 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for catheters interactions were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for catheters interactions.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 3
2 Participants
Number of Responders for Physician Assessment for Catheters Interactions
EP Lab recording equipment: Score 7
4 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 4
4 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 6
3 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 2
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 6
13 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 7
12 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 1
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
ICD or other implantable devices: Score 4
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 7
8 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 1
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 4
5 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Introducer tool on catheter: Score 5
8 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 2
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 4
5 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 5
9 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 6
12 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Sheath: Score 7
12 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 1
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 1
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 4
7 Participants
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 5
10 Participants
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 6
16 Participants
Number of Responders for Physician Assessment for Catheters Interactions
CARTO 3 System: Score 7
4 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Electrophysiology (EP) Lab recording equipment: Score 1
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
EP Lab recording equipment: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
EP Lab recording equipment: Score 3
2 Participants
Number of Responders for Physician Assessment for Catheters Interactions
EP Lab recording equipment: Score 4
6 Participants
Number of Responders for Physician Assessment for Catheters Interactions
EP Lab recording equipment: Score 5
16 Participants
Number of Responders for Physician Assessment for Catheters Interactions
EP Lab recording equipment: Score 6
11 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Pacing equipment: Score 5
12 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 4
6 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 5
9 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 6
12 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Irrigation bag and tubing: Score 7
12 Participants
Number of Responders for Physician Assessment for Catheters Interactions
Implantable cardioverter-defibrillators (ICD) or other implantable devices: Score 1
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
ICD or other implantable devices: Score 2
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
ICD or other implantable devices: Score 3
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
ICD or other implantable devices: Score 5
0 Participants
Number of Responders for Physician Assessment for Catheters Interactions
ICD or other implantable devices: Score 6
1 Participants
Number of Responders for Physician Assessment for Catheters Interactions
ICD or other implantable devices: Score 7
0 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for arrhythmogenicity were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for arrhythmogenicity.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 5
10 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 1
0 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 1
0 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 2
0 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 3
1 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 4
1 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 6
20 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to the PENTARAY catheter: Score 7
8 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 2
0 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 3
1 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 4
5 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 5
7 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 6
12 Participants
Number of Responders for Physician Assessment for Arrhythmogenicity
Compared to other competitive multielectrode catheters: Score 7
4 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'N' (number of participants analyzed) signifies participants evaluated for this outcome measure and 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for design and coverage for confirming PVI were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for design and coverage for confirming PVI.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=30 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 1
0 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 2
0 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 3
1 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 4
1 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 5
8 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 6
12 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to the PENTARAY catheter: Score 7
8 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 1
0 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 2
0 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 3
1 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 4
1 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 5
10 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 6
6 Participants
Number of Responders for Physician Assessment for Design and Coverage for Confirming Pulmonary Vein Isolation (PVI)
Compared to other competitive multielectrode catheters: Score 7
3 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for ability to characterize the tissue were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for ability to characterize the tissue.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 2
0 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 3
0 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 4
8 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 7
1 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 5
9 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 6
10 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 1
0 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 2
0 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 3
1 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 4
5 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 5
10 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 6
17 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to the PENTARAY catheter: Score 7
7 Participants
Number of Responders for Physician Assessment for Ability to Characterize the Tissue
Compared to other competitive multielectrode catheters: Score 1
0 Participants

SECONDARY outcome

Timeframe: Up to 29 weeks

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter. Here, 'n' (number analyzed) is defined as participants analyzed for specified categories.

Number of responders for physician assessment for ability to identify arrhythmia circuit or source correctly were reported. A post-procedure survey of 11 questions, each with individual sub-questions were asked. Each question/sub-question was answered by the physician using a Likert scale of 1 to 7 (1=poor and 7=excellent). Responders refers to participants with physician assessment for ability to identify arrhythmia circuit or source correctly.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 5
14 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 4
5 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 5
14 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 6
7 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 1
0 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 2
1 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 3
0 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 4
3 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 6
18 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to the PENTARAY catheter: Score 7
4 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 1
0 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 2
0 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 3
1 Participants
Number of Responders for Physician Assessment for Ability to Identify Arrhythmia Circuit or Source Correctly
Compared to other competitive multielectrode catheters: Score 7
1 Participants

SECONDARY outcome

Timeframe: Up to 7 days of index procedure on Day 1

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.

Number of participants with SAEs excluding investigational catheter related within 7 days of index procedure were reported. An AE is any untoward medical occurrence in a participant whether or not related to the investigational device. SAE is any AE that results in: death, persistent or significant disability/incapacity, requires inpatient hospitalization or prolongation of existing hospitalization, is life-threatening experience, is a congenital anomaly/birth defect and may jeopardize participant and/or may require medical or surgical intervention to prevent one of the outcomes listed above.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Participants With SAEs Excluding Investigational Catheter Related Within 7 Days of Index Procedure
3 Participants

SECONDARY outcome

Timeframe: Up to 7 days of index procedure on Day 1

Population: The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.

Number of participants with non-serious AEs within 7 days of index procedure related to the investigational catheter were reported. An AE is any untoward medical occurrence in a participant whether or not related to the investigational device.

Outcome measures

Outcome measures
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 Participants
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Number of Participants With Non-serious Adverse Events Within 7 Days of Index Procedure Related to the Investigational Catheter
1 Participants

Adverse Events

Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)

Serious events: 4 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 participants at risk
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Cardiac disorders
Atrioventricular block
2.5%
1/40 • Number of events 1 • From screening up to 29 weeks
The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.
Cardiac disorders
Cardiac tamponade
2.5%
1/40 • Number of events 1 • From screening up to 29 weeks
The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.
Cardiac disorders
Pericardial effusion
2.5%
1/40 • Number of events 1 • From screening up to 29 weeks
The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.
Cardiac disorders
Transient complete atrioventricular block
2.5%
1/40 • Number of events 1 • From screening up to 29 weeks
The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.

Other adverse events

Other adverse events
Measure
Multi-electrode Electrocardiogram (ECG) Mapping Catheter (Investigational Catheter)
n=40 participants at risk
Participants diagnosed with cardiac arrhythmias who were scheduled to have a clinically-indicated catheter mapping and ablation procedure of arrhythmia management for atrial and ventricular procedures, underwent pre-ablation mapping of the chambers of interest using the multi-electrode ECG mapping catheter (investigational catheter) prior to a standard of care ablation procedure.
Cardiac disorders
Transient right bundle branch block
2.5%
1/40 • Number of events 1 • From screening up to 29 weeks
The safety analysis set consisted of all enrolled participants who underwent insertion of the study catheter.

Additional Information

Senior Director Clinical Research

Biosense Webster, Inc.

Phone: 844-434-4210

Results disclosure agreements

  • Principal investigator is a sponsor employee Publications and/or presentation of clinical investigation results will be coordinated and governed between Biosense Webster, Inc., the clinical investigation author(s) and if applicable local law. Authorship will be determined prior to development of any manuscript.
  • Publication restrictions are in place

Restriction type: OTHER